Glenmark’s Lonhala Version Hits ‘Intriguing’ Indian Nebulizer Market
Executive Summary
Glenmark’s nebulized, long-acting muscarinic antagonist for COPD has hit the Indian market. Delivered via a novel mesh nebulizer, it is seen as likely catering to a relatively small patient group.